Eli Lilly bets on multi-dose Zepbound pen in GLP-1 retention push
Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart: a new injector pen, a new box, another reminder to
Oil
Oil
US stocks open flat after Trump raises global tariffs to 15%
US equities were little changed on Monday after President Donald Trump announced an increase in global tariffs to 15%, following a Supreme Court
Bitcoin
ETH eyes further dip as Buterin looks to sell more holdings
The cryptocurrency market opened the new weekly candle bearish, as Bitcoin, Ether, and XRP tested key support levels. Ether, the second-largest cryptocurrency by
Bitcoin
Citrini research: S&P 500 to drop 38% from 2026 highs by June 2028
In a sweeping and provocative macro-analysis titled “The 2028 Global Intelligence Crisis,” Citrini Research has outlined a sobering vision of a financial future
Bitcoin
Why is Arcellx stock up 80% today? Gilead’s $7.8B answer
Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday after Gilead Sciences agreed to buy the cancer-therapy developer in a
Bitcoin
South Korea debates bank control over won stablecoins
South Korea’s stablecoin framework is facing renewed scrutiny as the country’s central bank urges lawmakers to keep control of won-pegged digital tokens within
Bitcoin
Finland’s IQM leads Europe’s quantum push with US listing plan
Finland’s IQM is positioning itself at the centre of Europe’s quantum technology ambitions as it prepares to enter public markets in the US.
Bitcoin
We predicted the Blue Owl stock price crash to $10
Blue Owl stock price has crashed in the past few months, turning one of the most blue-chip financial giants into a fallen angel.
Bitcoin
Trump tariffs repriced after SCOTUS ruling: winners and losers
Fridays used to be reserved for routine headlines. But since Donald Trump’s reelection, every Friday seems like a bombshell day. And last Friday
Bitcoin
Merck creates separate oncology arm ahead of Keytruda patent loss
Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across its